Next Article in Journal
The Impact of Post-Analytical Tools on New York Screening for Krabbe Disease and Pompe Disease
Next Article in Special Issue
Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy
Previous Article in Journal / Special Issue
Evaluation of a Two-Tier Screening Pathway for Congenital Adrenal Hyperplasia in the New South Wales Newborn Screening Programme
Article

Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States

Association of Public Health Laboratories, Silver Spring, MD 20910, USA
*
Author to whom correspondence should be addressed.
Int. J. Neonatal Screen. 2020, 6(3), 64; https://doi.org/10.3390/ijns6030064
Received: 8 June 2020 / Revised: 6 August 2020 / Accepted: 11 August 2020 / Published: 14 August 2020
(This article belongs to the Special Issue CAH Screening—Challenges and Opportunities)
Newborn screening (NBS) is a state-based public health program that aims to identify newborns at risk of certain disorders in the first days after birth to prevent permanent disability or death. Disorders on the Health and Human Services Federal Advisory Committee’s Recommended Uniform Screening Panel (RUSP) have been adopted by most state NBS programs; however, each state mandates specific disorders to be screened and implements their own system processes. Congenital adrenal hyperplasia (CAH) was added to the RUSP in 2005, and currently all 53 NBS programs universally screen for it. This paper provides a landscape of CAH screening in the United States, utilizing data voluntarily entered by state NBS programs in the Newborn Screening Technical assistance and Evaluation Program data repository. Data reported encompasses NBS state profile data (follow-up, disorder testing and the reporting of processes and methodologies for screening), quality indicator data (timeliness of CAH NBS) and confirmed cases. This comprehensive landscape analysis compares the CAH NBS systems across the US. This is vital in ultimately ensuring that newborns with CAH at risk of salt crisis receive appropriate intervention in a timely manner. View Full-Text
Keywords: newborn screening; congenital adrenal hyperplasia; NewSTEPs newborn screening; congenital adrenal hyperplasia; NewSTEPs
Show Figures

Figure 1

MDPI and ACS Style

Edelman, S.; Desai, H.; Pigg, T.; Yusuf, C.; Ojodu, J. Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States. Int. J. Neonatal Screen. 2020, 6, 64. https://doi.org/10.3390/ijns6030064

AMA Style

Edelman S, Desai H, Pigg T, Yusuf C, Ojodu J. Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States. International Journal of Neonatal Screening. 2020; 6(3):64. https://doi.org/10.3390/ijns6030064

Chicago/Turabian Style

Edelman, Sari, Hiral Desai, Trey Pigg, Careema Yusuf, and Jelili Ojodu. 2020. "Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States" International Journal of Neonatal Screening 6, no. 3: 64. https://doi.org/10.3390/ijns6030064

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop